Recent Updates
Recently added Catalysts
NTLA

Intellia Therapeutics to Present at August Healthcare Investor Conference

Tuesday, July 30, 2019 1 min read
Key Takeaway: CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at the following upcoming healthcare con

Full Press Release Details

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at the following upcoming healthcare conference in August:
Wednesday, August 7, 2019
SVB Leerink Spotlight Series: Rare & Genetic Diseases Conference
Location: Boston, MA
About Intellia Therapeutics
lina.li@intelliatx.com
Jennifer Mound Smoter
Senior Vice President
External Affairs & Communications
jenn.smoter@intelliatx.com
Tags: NTLA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jul 30, 2019